NEWS and OPINIONS
Researchers Develop Better Ways to Culture Living Heart Cells on the International Space Station
From NASA.gov - Link to Article May 27, 2021 - As part of preparing for an experiment aboard the International Space Station, researchers explored new ways to culture living heart cells for microgravity research. They found that cryopreservation, a process of storing...
Scientists find small molecule cocktail to improve stem cell use in research, medicine
NIH/National Center for Advancing Translational Sciences (NCATS) Researchers at the National Institutes of Health (NIH) have devised a four-part small-molecule cocktail that can protect stem cells called induced pluripotent stem cells (iPSCs) from stress and maintain...
Artregen, Dr. Desirée Cox’s Transformative Art Brand, To Be Featured In British Vogue’s Summer Art Campaign
LONDON, UK (MAY 26, 2021.) ArtRegen announced today that Dr. Desirée Cox’s transformative art will be showcased in British Vogue’s summer art campaign. From May to July 2021, select one-of-a-kind paintings from Dr. Desirée’s exclusive collection – all available for...
10 serious COVID patients given Israeli drug, leave hospital in one day
Photo Caption: MesenCure development entrepreneurs (from right): Dr. Dror Ben David, Dr. Shai Meretzki and Tomer Bronstein From The Jerusalem Post (link to article) - An Israeli biotechnology company has claimed a 100% success rate in the first 10 patients treated...
Nobel laureate calls for research funds to solve the mystery of aging
Image Caption: A group of induced pluripotent stem cells emit a pale yellow-green light, but the cells surrounded by iPS cells do not because they have already turned into other cells. (Provided by Kyoto University) Scientists in Japan from fiscal 2023 will...
New research institute and center launched to advance regenerative medicine in Singapore
The first project will explore regenerative cell therapy to treat blood cancers, heart failure and eye degeneration NEWS RELEASE 21 May 2021, Singapore - (From EurekAlert website - Link to article) - The SingHealth Duke-NUS Academic Medical Centre (AMC) announced the...
U.S. Senate Clears NCBI Re-Authorization
Legislation is headed to President's desk for signature May 19, 2021 - The U.S. Senate has unanimously approved re-authorization of the National Cord Blood Inventory (NCBI) at up to $23 million annually through Fiscal Year 2026. The Senate sponsors of the bipartisan...
Longeveron Announces the Hiring of Dan Gincel, Ph.D., as Senior Vice President, Strategic Collaborations & Scientific Affairs
Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research Fund MIAMI, May 18, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
Noble Capital Markets and Channelchek to Host Investor Forum C-Suite Interviews During Prestigious 16th Annual World Stem Cell Summit
BOCA RATON, Fla., May 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Noble Capital Markets (“Noble”), a research-driven investment bank, today announces its platinum-level sponsorship of, and collaboration with, the 16th World Stem Cell Summit, to be held virtually...
Amritha Jaishankar, Ph.D. Appointed As New Executive Director of Maryland Stem Cell Research Fund
COLUMBIA, Md. (May 10, 2021)—The Maryland Stem Cell Research Commission has approved funding to its second-round of 2021 recipients for a total of $6,052,901. The Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director - Programs &...
Human mesenchymal stem cells show promise in treating chronic lung infections
Durham, NC – A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western...
Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announces it has been selected to...